Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response of Intranasal Fluticasone Propionate in Allergic Rhinitis
NCT00848965Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2007
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate in seasonal allergic rhinitis (SAR), sponsored by GSK. Started Oct 2007; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00848965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00848965.